Many people with diabetes prefer an insulin pump to insulin injections. Here's how to know if it's right for you.

After more than a week of testimony and nearly two hours of closing arguments, Sarah Hartsfield has been found guilty of ...

CMS Administrator Mehmet Oz, MD, MBA, said his agency will make an announcement on potential Medicare coverage of GLP-1 ...

Authorities have filed 73 charges, including 50 felonies, against Crystal Scott, who is accused of posing as a nurse and administering insulin to children as yo ...

GLP-1 RA use was associated with improved cardiometabolic outcomes among pediatric patients with type 2 diabetes and obesity.

Afrezza is a rapid-acting inhaled human insulin that is currently approved to improve glycemic control in adults with diabetes mellitus.

( NewsNation) — Drugmaker MannKind announced that its inhaled insulin, Afrezza, has been approved for an application to help ...

To inject insulin safely and effectively, it's important to follow your doctor's advice and remember a few key steps.

If approved, it would be the first needle-free insulin option for pediatric patients in 100+ years of insulin therapy sBLA submission based on ...

The recent FDA approval of topical JAK inhibitors for children 2 years or older marks a significant advancement in pediatric atopic dermatitis treatment. Previously approved only for individuals 12 ...

Shareholders to Receive $54 Per Share in Cash and CVR of $6 Per Share Advances Akero’s Mission of Bringing Novel Therapies to Patients with High Unmet Medical Needs SOUTH SAN FRANCISCO, Calif., Oct.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings ...